Cargando…
Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study
BACKGROUND: Guidelines for general hypertension treatment do not recommend the combined use of renin-angiotensin-aldosterone system (RAAS) inhibitors due to the risk of hyperkalemia. However, a recent clinical trial showed that polycystic kidney disease (PKD) patients had infrequent episodes of hype...
Autores principales: | Kim, Hyoungnae, Park, Seohyun, Jhee, Jong Hyun, Yun, Hae-Ryong, Park, Jung Tak, Han, Seung Hyeok, Lee, Joongyub, Kim, Soo Wan, Kim, Yeong Hoon, Oh, Yun Kyu, Kang, Shin-Wook, Choi, Kyu Hun, Yoo, Tae-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434770/ https://www.ncbi.nlm.nih.gov/pubmed/30909873 http://dx.doi.org/10.1186/s12882-019-1292-3 |
Ejemplares similares
-
Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease
por: Park, Hayne Cho, et al.
Publicado: (2020) -
Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease
por: Jhee, Jong Hyun, et al.
Publicado: (2017) -
Permissive fluid volume in adult patients undergoing extracorporeal membrane oxygenation treatment
por: Kim, Hyoungnae, et al.
Publicado: (2018) -
Extracellular Fluid Excess Is Significantly Associated With Coronary Artery Calcification in Patients With Chronic Kidney Disease
por: Park, Seohyun, et al.
Publicado: (2018) -
Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy
por: Jung, Su-Young, et al.
Publicado: (2018)